Dan Medica South Ltd
United Kingdom (ex Northern Ireland) GB-MF-000026261 Last updated 23 May 2026
Is this your brand? Sign in to claim this brand
- Devices
- 2
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
Treat-Eezi Ref TEM60
Treat-Eezi Ref TEHR
Related companies
Authorised representatives
What Dan Medica South Ltd makes
Dan Medica South Ltd manufactures the TREAT-EEZI, a Class I medical device designed for wound care or minor skin treatments, likely intended for at-home or clinical use.
The device is listed in the EU’s eudamed registry under Class I classification and is based in the United Kingdom.
Frequently asked questions
What types of medical devices does Dan Medica South Ltd manufacture?
Dan Medica South Ltd manufactures the TREAT-EEZI, a Class I medical device. Based on the description, this device appears to be intended for wound care or minor skin treatments, likely suitable for either at-home or clinical use. Class I devices are generally considered low-risk and often include items like bandages, wound dressings, or simple skin treatment tools.
Where is Dan Medica South Ltd based?
Dan Medica South Ltd is based in the United Kingdom (GB). This location is relevant for regulatory compliance, as it influences which regulatory bodies and databases the company interacts with, such as the EU’s eudamed registry.
Which regulatory registries list Dan Medica South Ltd’s devices?
Dan Medica South Ltd’s devices are listed in the EU’s eudamed registry, which is the official database for medical devices within the European Economic Area. Listing in eudamed is required for compliance with EU Medical Device Regulations (MDR) or In Vitro Diagnostic Regulation (IVDR), ensuring transparency and traceability of Class I devices.
How are Dan Medica South Ltd’s devices classified under medical device regulations?
Dan Medica South Ltd’s devices, such as the TREAT-EEZI, are classified as Class I under medical device regulations. This classification is determined by factors like the device’s intended purpose, risk level, and potential impact on patient safety. Class I devices are typically the lowest risk and often require minimal regulatory oversight, though compliance with general safety and performance requirements still applies.
Information
- Country
- United Kingdom (ex Northern Ireland)
- Address
- 2, Upperton Gardens, , Eastbourne, United Kingdom (ex Northern Ireland)
- Website
- www.danmedicasouth.co.uk
- [email protected]
- Phone
- +442081332851
- PRRC contact
- lynne timm
- EUDAMED SRN
- GB-MF-000026261